Advanz Pharma Generics (UK) Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Advanz Pharma Generics (UK) Limited - overview
Location
London, England, UK
Primary Industry
Pharmaceuticals
About
Based in London, UK, Advanz Pharma Generics (UK) Limited, involved in the development, registration, and commercialization of generic pharmaceutical products.
Current Investors
Amdipharm Group, AMCo
Primary Industry
Pharmaceuticals
Sub Industries
Specialty Pharmaceuticals
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Advanz Pharma Generics (UK) Limited - timeline of key events
Advanz Pharma Generics (UK) Limited - financials
| Fiscal Year Ended | Mar 31, 2010 | Mar 31, 2011 | Mar 31, 2012 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 11,414,519 | 13,076,481 | 13,160,822 | 20,004,238 | 27,465,480 | 29,283,345 | 52,491,384 | 74,734,603 | 46,653,383 | 38,657,701 | 47,517,519 | 40,596,647 | 41,020,770 | - | - | - |
| % Revenue Growth (YoY) | - | 14.6% | 0.6% | - | - | 6.6% | 79.3% | 42.4% | (37.6%) | (17.1%) | 22.9% | (14.6%) | 1.0% | - | - | - |
| EBITDA (USD) | 4,543,184 | 5,596,577 | 6,522,118 | 6,159,141 | 17,730,784 | 2,620,743 | 7,808,587 | 10,146,825 | 2,006,094 | 1,662,282 | 2,043,252 | 1,745,655 | 1,763,894 | - | - | - |
| Operating Income (USD) | 4,543,184 | 5,596,577 | 6,522,118 | 6,159,141 | 17,730,784 | 2,620,743 | 7,808,587 | 10,146,825 | 2,006,094 | 1,662,282 | 2,043,252 | 1,745,655 | 1,763,894 | - | - | - |
| Operating Margin | 39.8% | 42.8% | 49.6% | 30.8% | 64.6% | 8.9% | 14.9% | 13.6% | 4.3% | 4.3% | 4.3% | 4.3% | 4.3% | - | - | - |
| % EBITDA Margin | 39.8% | 42.8% | 49.6% | 30.8% | 64.6% | 8.9% | 14.9% | 13.6% | 4.3% | 4.3% | 4.3% | 4.3% | 4.3% | - | - | - |
| NET Income (USD) | 3,229,425 | 4,015,161 | 5,208,489 | 4,106,652 | 14,769,465 | 2,060,433 | 6,226,660 | 8,172,556 | 1,621,072 | 1,369,305 | 2,081,222 | 1,754,672 | 1,764,333 | - | - | - |
| % Net Margin | 28.3% | 30.7% | 39.6% | 20.5% | 53.8% | 7.0% | 11.9% | 10.9% | 3.5% | 3.5% | 4.4% | 4.3% | 4.3% | - | - | - |
Advanz Pharma Generics (UK) Limited - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | Advanz Pharma Generics (UK) Limited | - |
Displaying 1 - 1 of 1
Advanz Pharma Generics (UK) Limited - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.